(1 - 31 from 54
)
FDA Grants RUCONEST® (C1 Esterase Inhibitor ...
www.marketwatch.com
Sijmen de Vries, Pharming's CEO, commented: "Pharming strived to make RUCONEST available to the HAE patient community in the US, ...
Pharming and Cytobioteck Announce Distribution ...
www.finanznachrichten.de
Sijmen de Vries, Pharming's CEO commented: we are very pleased that Cytobioteck will be engaged in the distribution of RUCONEST in ...
Morphochem AG, of Munich, Germany, appointed Sijmen de ...
www.highbeam.com
Morphochem AG, of Munich, Germany, appointed Sijmen de Vries CEO. De Vries was most recently... | Article from BioWorld International July ...
Exclusive Video Q&A With Sijmen de Vries, CEO of Pharming
www.marketwired.com
Sijmen de Vries, the Chief Executive Officer of the company, recently sat down with BioMedReports to discuss the firm's truly innovative ...
sorted by relevance / date